Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.
Covering the life sciences inside and out
Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.
By discouraging change, universities are stunting scientific innovation, leadership, and growth.
Researchers identify two new DNA repair systems, in addition to four that were already known, that can attack unprotected telomeres.
A lack of methodological detail in the published literature threatens the foundation of scientific discourse.
Research on an 18th and 19th century Finnish population suggests that agriculture and monogamy may not have stopped human evolution.
A US Fish and Wildlife official responds to the assertion that the northern spotted owl is being mismanaged by government.
With 12 new tuberculosis vaccines in clinical development, a plan is needed to introduce the most effective ones throughout the world.
Scientists show that manmade nucleic acids can replicate and evolve, ushering in a new era in synthetic biology.
Introducing DELSA Global, a community initiative to connect experts, share data, and democratize science.
Remarkable findings of ingested plant miRNA in animal liver and blood draw speculation about the study’s validity.